J.P. Morgan Reaffirms Their Hold Rating on Tempus AI, Inc. Class A (TEM)
at www.tipranks.com (Thu, 19-Nov 7:45 AM)
at www.tipranks.com (Thu, 19-Nov 7:45 AM)
Tempus AI to receive $200M as AstraZeneca extends oncology deal
at seekingalpha.com (Wed, 18-Nov 10:16 AM)
Tempus AI and AstraZeneca Extend Strategic Services Agreement
at www.tipranks.com (Wed, 18-Nov 8:57 AM)
Diagnostic stocks safe from proposed crackdown on Medicare fraud
at seekingalpha.com (Tue, 17-Nov 10:41 AM)
Cathie Wood's weekly recap: boosts Nvidia, CoreWeave, Archer Aviation; pares Tempus AI, Palantir
at seekingalpha.com (Mon, 16-Nov 7:05 AM)
Tempus posts record Q3 revenue of $411.5 million as Data & Applications grows 33%
Market Chameleon (Mon, 2-Nov 7:10 AM)
Tempus spotlights AI pre-screening in advanced NSCLC with 60,459-case analysis ahead of ESMO 2026
Market Chameleon (Tue, 20-Oct 7:14 AM)
Tempus sets Nov. 2 Q3 2026 earnings call with CEO Eric Lefkofsky and CFO Jim Rogers
Market Chameleon (Fri, 16-Oct 9:38 AM)
Market Chameleon (Tue, 13-Oct 8:42 AM)
Market Chameleon (Wed, 7-Oct 8:37 AM)
Market Chameleon (Mon, 28-Sep 8:16 AM)
Tempus Extends Recursion Partnership Through 2029 and Adds License to TxFM RNA Foundation Model
Market Chameleon (Mon, 21-Sep 9:48 AM)
Market Chameleon (Mon, 24-Aug 8:52 AM)